Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care

Clinical Infectious Diseases

Volumn 60, Issue 8, 2015, Pages 1278-1280

  Klein, Daniel B ^a   Leyden, Wendy A ^b   Xu, Lanfang ^c   Chao, Chun R ^c   Horberg, Michael A ^d   Towner, William J ^e   Hurley, Leo B ^b   Marcus, Julia L ^b   Quesenberry, Charles P ^b   Silverberg, Michael J ^b  

^a Kaiser Permanente   (United States)

^b DIVISION OF RESEARCH   (United States)

^c Department of Internal Medicine ^*  (United States)

^d Mid Atlantic Permanente Research Institute   (United States)

^e Section of Infectious Diseases   (United States)

Author keywords

HIV; myocardial infarction; secular trend

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; FEMALE; HEALTH CARE ACCESS; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RISK REDUCTION; ADOLESCENT; COHORT ANALYSIS; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK; YOUNG ADULT;

EID: 84926332657     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ014     Document Type: Article

References (12)

1. Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013; 8:e81355.
2. Freiberg MS, Chang CC, Kuller LH, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 2013; 173:614-22.
3. Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 2003; 17:2479-86.
4. Silverberg MJ, Leyden WA, Xu L, et al. Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care. J Acquir Immune Defic Syndr 2014; 65:160-6.
5. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007; 92:2506-12.
6. Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010; 362:2155-65.
7. Klein D, Hurley LB, Quesenberry CP Jr, Sidney S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?. J Acquir Immune Defic Syndr 2002; 30:471-7.
8. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, 2014. Available at: http://aidsinfo.nih.gov/contentfiles/AdultandAdolescent GL.pdf. Accessed 20 January 2015.
9. Lang S, Mary-Krause M, Simon A, et al. HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Clin Infect Dis 2012; 55:600-7.
10. Lichtenstein KA, Armon C, Buchacz K, et al. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clin Infect Dis 2010; 51:435-47.
11. Triant VA, Regan S, Lee H, et al. Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system. J Acquir Immune Defic Syndr 2010; 55:615-9.
12. Lo J, Plutzky J. The biology of atherosclerosis: general paradigms and distinct pathogenic mechanisms among HIV-infected patients. J Infect Dis 2012; 205(suppl 3):S368-74.